CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders


Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Meet Our Editorial Board Member

Volume:20   Issue: 6
Pp: 479-479
Thakur G. Singh
DOI: 10.2174/187152732006210831144234
Published on: 31 August, 2021

Does Human Alpha-Synuclein Behave Like Prions?

Volume:20   Issue: 6
Pp: 480-486
Yasir Hasan Siddique*
DOI: 10.2174/1871527320666210420140123
Published on: 20 April, 2021

Drosophila melanogaster a Versatile Model of Parkinson’s Disease

Volume:20   Issue: 6
Pp: 487-530
Falaq Naz and Yasir Hasan Siddique*
DOI: 10.2174/1871527320666210208125912
Published on: 08 February, 2021

Targeting Brain Cancer Cells by Nanorobot, A Promising Nanovehicle: New Challenges and Future Perspectives

Volume:20   Issue: 6
Pp: 531-539
Chandra Kishore* and Priyanka Bhadra
DOI: 10.2174/1871527320666210526154801
Published on: 30 June, 2021

Deciphering the Influence of Cigarette Smoke Carcinogens on CNS Associated Biomolecules: A Computational Synergistic Approach

Volume:20   Issue: 6
Pp: 540-555
Qazi Mohammad Sajid Jamal*, Ali H. Alharbi, Anupam Dhasmana, Anukriti, Fahad Albejaidi and Mohammad Sajid
DOI: 10.2174/1871527320666210309142714
Published on: 09 March, 2021

In-Silico Validation and Fabrication of Matrix Diffusion-Based Polymeric Transdermal Patches for Repurposing Gabapentin Hydrochloride in Neuropathic Pain

Volume:20   Issue: 6
Pp: 556-570
Manisha Singh*, Shriya Agarwal, Pranav Pancham, Vinayak Agarwal, Harleen Kaur and Ramneek Kaur
DOI: 10.2174/1871527320666210212111158
Published on: 11 February, 2021